Clinical Research Directory

Inclusion Criteria * Subject 18 years of age. * Willing and able to provide written informed consent and comply with study procedures. * Patients attending a definitive care team with research capabilities which has been enroled in this collection study. * Patients who can read and understand written English. * The subject must present as one of the following cohorts: 1. Group A - Embolism Cohort - Patients presenting with symptoms indicative of thromboembolic events. 2. Group B - Infection or Inflammation Cohort - Patients presenting with symptoms indicative of infection or inflammatory disorders. 3. Group C - Cardiovascular Cohort - Patients presenting with symptoms indicative of heart failure or acute coronary syndrome. 4. Group D - Renal Cohort - Patients presenting with symptoms indicative of renal disorders. 5. Group E - Other Cohort. - Patients who are not eligible for any of the above groups. Exclusion Criteria * Subject \<18 years of age. * Vulnerable populations deemed inappropriate for the study by the sites Principal Investigator. * Patients who have previously been enroled in any LumiraDx NOVEL study in the past 3 months and re-entry would breach the 24mL and or 6 fingersitck maximums.